Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms.

MLA

Gunes, Arzu, and Marja-Liisa Dahl. “Variation in CYP1A2 Activity and Its Clinical Implications: Influence of Environmental Factors and Genetic Polymorphisms.” Pharmacogenomics, vol. 9, no. 5, May 2008, pp. 625–37. EBSCOhost, https://doi.org/10.2217/14622416.9.5.625.

APA

Gunes, A., & Dahl, M.-L. (2008). Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms. Pharmacogenomics, 9(5), 625–637. https://doi.org/10.2217/14622416.9.5.625

Chicago

Gunes, Arzu, and Marja-Liisa Dahl. 2008. “Variation in CYP1A2 Activity and Its Clinical Implications: Influence of Environmental Factors and Genetic Polymorphisms.” Pharmacogenomics 9 (5): 625–37. doi:10.2217/14622416.9.5.625.